{"nct_id":"NCT00093639","title":"Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate","status":"COMPLETED","status_verified_date":"2013-04","start_date":"2004-08","start_date_type":null,"primary_completion_date":"2006-08","primary_completion_date_type":"ACTUAL","completion_date":"2006-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}